REQUEST A DEMO
Total
USD $0.00
Search more companies

Marwald S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Marwald S.R.O. Profile Updated: October 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Marwald S.R.O. is an enterprise in Czech Republic, with the main office in Hlina. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on November 29, 2012. It currently has a total number of 1 - 5 (2023) employees. The company’s latest financial report indicates a net sales revenue drop of 45.74% in 2023. Its’ total assets recorded a negative growth of 11.44%. The net profit margin of Marwald S.R.O. increased by 43.09% in 2023.

Headquarters
Hlina 57
Hlina; Jihomoravsky; Postal Code: 66491

Contact Details: Purchase the Marwald S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Marwald S.R.O. report to view the information.
Outstanding Shares:
Purchase the Marwald S.R.O. report to view the information.
Registered Capital:
Purchase the Marwald S.R.O. report to view the information.
Incorporation Date:
November 29, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Marwald S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-45.74%
Total operating revenue
-44.8%
Operating profit (EBIT)
67.58%
EBITDA
-51.2%
Net Profit (Loss) for the Period
69.88%
Total assets
-11.44%
Total equity
-11.02%
Operating Profit Margin (ROS)
34.07%
Net Profit Margin
43.09%
Return on Equity (ROE)
24.2%
Quick Ratio
24.89%
Cash Ratio
22.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?